Skip to main content
Clinical Trials/NCT01581645
NCT01581645
Completed
Early Phase 1

Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)

Mayo Clinic1 site in 1 country11 target enrollmentMay 2012

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Mayo Clinic
Enrollment
11
Locations
1
Primary Endpoint
Improvement in Gait
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Detailed Description

Can patients walk faster and have less freezing when using the mobilaser then when not using it

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
December 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jay A. Van Gerpen

Assistant Professor of Neurology

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Parkinsonian patients with Freezing of Gait or Gait hesitation.
  • Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing)
  • Must have a constant caregiver

Exclusion Criteria

  • No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris;
  • Severe arthritis;
  • Cerebellar or sensory ataxia;
  • Recent knee or hip surgery

Outcomes

Primary Outcomes

Improvement in Gait

Time Frame: 6 weeks

Study Sites (1)

Loading locations...

Similar Trials